Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.RMD Open|September 8, 2017
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliabilitySandrine Jousse-Joulin, Emmanuel Nowak, Divi Cornec, et al.Journal of Innate Immunity|March 18, 2016
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic FibrosisLaurent Meijer, Deborah J Nelson, Vladimir Riazanski, et al.RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Maintenance of remission after tocilizumab withdrawal in patients with glucocorticoid-dependent polymyalgia rheumaticaBaptiste Chevet, Aghiles Souki, Emmanuel Nowak, et al.Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort StudyAlice Tison, Gilles Quéré, Laurent Misery, et al.Pageof 10